Wealthcare Advisory Partners LLC Cara Therapeutics, Inc. Transaction History

Wealthcare Advisory Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$12.38 - $29.19 $3,231 - $7,618	-261 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$15.07 - $21.71 $3,933 - $5,666	261 New	261 $6,000
Q2 2020 Jul 29, 2020	SELL	$12.39 - $17.33 $2,552 - $3,569	-206 Closed	0 $0
Q1 2020 Apr 29, 2020	SELL	$9.12 - $17.78 $4,560 - $8,890	-500 Reduced 70.82%	206 $3,000
Q4 2019 Jan 29, 2020	BUY	$16.11 - $25.98 $3,318 - $5,351	206 Added 41.2%	706 $11,000
Q3 2019 Oct 17, 2019	BUY	$18.28 - $26.91 $9,140 - $13,455	500 New	500 $9,000

16.4M

55K

500

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $18.3M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.